Nasso, Cecilia
 Distribuzione geografica
Continente #
NA - Nord America 1.763
AS - Asia 1.153
EU - Europa 988
SA - Sud America 196
AF - Africa 41
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 4.148
Nazione #
US - Stati Uniti d'America 1.714
SG - Singapore 347
CN - Cina 329
IT - Italia 242
IE - Irlanda 155
VN - Vietnam 146
GB - Regno Unito 135
BR - Brasile 133
HK - Hong Kong 120
DE - Germania 99
SE - Svezia 70
FR - Francia 59
RU - Federazione Russa 52
FI - Finlandia 46
KR - Corea 39
IN - India 37
ID - Indonesia 33
AR - Argentina 28
CA - Canada 24
PL - Polonia 19
BD - Bangladesh 14
BE - Belgio 14
ZA - Sudafrica 14
CZ - Repubblica Ceca 13
MX - Messico 13
NL - Olanda 13
UA - Ucraina 13
BG - Bulgaria 11
ES - Italia 11
CO - Colombia 10
IQ - Iraq 9
LT - Lituania 9
TR - Turchia 9
AT - Austria 8
CL - Cile 8
EC - Ecuador 8
JP - Giappone 8
MY - Malesia 7
KE - Kenya 6
SA - Arabia Saudita 6
TN - Tunisia 6
MA - Marocco 5
PH - Filippine 5
UZ - Uzbekistan 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
EG - Egitto 4
PK - Pakistan 4
SY - Repubblica araba siriana 4
AU - Australia 3
CR - Costa Rica 3
ET - Etiopia 3
EU - Europa 3
JM - Giamaica 3
JO - Giordania 3
RO - Romania 3
AZ - Azerbaigian 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
HR - Croazia 2
IL - Israele 2
KG - Kirghizistan 2
KZ - Kazakistan 2
NO - Norvegia 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
QA - Qatar 2
RS - Serbia 2
TH - Thailandia 2
TW - Taiwan 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DZ - Algeria 1
GR - Grecia 1
HN - Honduras 1
HT - Haiti 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.148
Città #
Ashburn 217
Santa Clara 214
Singapore 192
Chandler 161
Dublin 153
Hong Kong 118
San Jose 108
Fairfield 105
Hefei 97
Dallas 84
Beijing 61
Nyköping 57
Ho Chi Minh City 53
London 53
Los Angeles 46
Helsinki 39
Hanoi 37
Shanghai 37
Wilmington 37
Seoul 36
New York 34
Houston 31
Ann Arbor 30
Munich 30
Seattle 29
Southend 29
The Dalles 28
Chicago 25
Council Bluffs 24
Jakarta 24
Modena 24
Cambridge 22
Lauterbourg 22
Moscow 20
Dearborn 17
Woodbridge 17
San Diego 15
São Paulo 14
Bremen 13
Milan 13
Paris 13
Bologna 12
Portsmouth 12
Princeton 12
Des Moines 11
Fremont 11
Mumbai 11
Sofia 11
Warsaw 11
Brooklyn 10
Buffalo 10
Falls Church 10
Guangzhou 10
Brno 9
Brussels 9
Orem 9
Parma 9
Toronto 9
Caprarola 8
Denver 8
Florence 8
Frankfurt am Main 8
Glasgow 8
Haiphong 8
Johannesburg 8
Boardman 6
Charlotte 6
Düsseldorf 6
Madrid 6
Nuremberg 6
Rome 6
Santorso 6
Tokyo 6
Changchun 5
Da Nang 5
Jacksonville 5
Kent 5
Montreal 5
Phoenix 5
Reggio Emilia 5
Savona 5
Tashkent 5
Atlanta 4
Baghdad 4
Biên Hòa 4
Carpi 4
Chennai 4
Columbus 4
Curitiba 4
Dong Ket 4
Gdansk 4
Harbin 4
Hải Dương 4
Mexico City 4
Porto Alegre 4
Quito 4
Redwood City 4
Salt Lake City 4
Turku 4
Acton 3
Totale 2.775
Nome #
Mutational Profile of Metastatic Breast Cancer Tissue in Patients Treated with Exemestane Plus Everolimus 348
Impact of body composition parameters on tumor response to neoadjuvant chemotherapy in operable breast cancer patients. 341
Endocrine-based targeted combination versus endocrine therapy alone as first-line treatment in elderly patients with hormone receptor-positive advanced breast cancer: Meta-analysis of phase II and III randomized clinical trials. 286
Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID era 267
Thromboembolism (TE) and adjuvant endocrine therapy (AET) in hormone receptor positive (HR+) early breast cancer (EBC): Did the evolution of treatment change the incidence of the adverse event? A metanalysis 263
Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant Chemotherapy. 261
PROGNOSIS AND RESPONSE TO NEOADJUVANT CHEMOTHERAPY ACCORDING TO HER2 EXPRESSION IN EARLY BREAST CANCER: a retrospective single institution analysis 243
Primary treatment strategy in elderly patients with hormone receptor positive early breast cancer: is breast cancer surgery. 226
TDM-1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: A meta-analysis 222
Adjuvant exemestane or tamoxifen plus ovarian suppression in premenopausal women: single institution analysis 216
Quality of life of therapies for hormone receptor positive advanced/metastatic breast cancer: Regulatory aspects and clinical impact in Europe 207
T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis 200
Long progression-free survival with cabozantinib in a heavily pretreated patient with metastatic renal cell carcinoma: a case report 172
Chasing Circulating Biomarkers in Renal Cell Carcinoma: the Case of Extracellular Vesicles and their miRNA Cargos 168
TDM-1 efficacy in trastuzumabpertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis 147
Quality of life of therapies for hormone receptor positive advanced/metastatic breast cancer (HR+/HER2- mBC): regulatory aspects and clinical impact in Europe 143
Cerebellar metastasis of ovarian cancer: a case report 139
Cabozantinib and nivolumab as first-line treatment in advanced renal cell carcinoma 136
Bone Metastases and Health in Prostate Cancer: From Pathophysiology to Clinical Implications 135
A Novel Molecular Profile of Hormone-Sensitive Prostate Cancer Defines High Risk Patients 70
Totale 4.190
Categoria #
all - tutte 16.035
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.035


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202175 0 0 0 0 0 0 0 0 0 25 6 44
2021/2022332 19 62 18 6 16 18 17 30 33 13 54 46
2022/2023569 40 65 38 39 35 58 9 54 178 11 20 22
2023/2024297 18 17 26 38 32 33 26 25 17 18 15 32
2024/2025987 30 7 24 74 166 123 84 72 135 61 85 126
2025/20261.675 129 74 220 183 260 112 279 105 141 172 0 0
Totale 4.190